Latest news
FDA clearance lets BriaCell test personalized prostate immunotherapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMTBCTX|Briacell Therapeutics Corp|Price:3.390|Chg%:-0.050 - TradingKeyTradingKey · Tue, 04 Aug 2026 06:59:52 GMTBCTX|Briacell Therapeutics Corp|Price:3.338|Chg%:-0.022 - TradingKeyTradingKey · Wed, 29 Jul 2026 17:53:19 GMTBriacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 07:00:00 GMTBriacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Mon, 27 Jul 2026 04:47:40 GMTBriacell Therapeutics Corp (BCTX) Income Statement - TradingKeyTradingKey · Sun, 26 Jul 2026 08:40:06 GMTBriacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Sun, 26 Jul 2026 07:47:57 GMTBCTX Q2 2026 Earnings: Narrower Loss Beats Estimates Amid Drug Development Progress - Revenue Estimate Trend - dars.gov.etdars.gov.et · Sun, 26 Jul 2026 02:37:44 GMT